Mosaic ImmunoEngineering, Inc. (OTCMKTS:CPMV – Get Free Report)’s stock price was down 30% during mid-day trading on Tuesday . The stock traded as low as $0.70 and last traded at $0.70. Approximately 1,796 shares traded hands during mid-day trading, an increase of 85% from the average daily volume of 969 shares. The stock had previously closed at $1.00.
Mosaic ImmunoEngineering Stock Down 30.0 %
The business’s 50 day moving average price is $0.88 and its 200-day moving average price is $0.92. The company has a market cap of $5.07 million, a PE ratio of -4.67 and a beta of 0.31.
Mosaic ImmunoEngineering Company Profile
Mosaic ImmunoEngineering, Inc, a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. Its lead immunotherapy product candidate, MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in humans and animals.
Featured Stories
- Five stocks we like better than Mosaic ImmunoEngineering
- Market Cap Calculator: How to Calculate Market Cap
- Hims & Hers Earnings Could Be a Game Changer—What to Do Now
- 5 discounted opportunities for dividend growth investors
- DeepSeek IPO Remains Far Off—Investors Eye 4 Chinese AI Stocks
- How to Calculate Inflation Rate
- Mortgage Market Bottom? Why Rocket Companies Could Be a Buy
Receive News & Ratings for Mosaic ImmunoEngineering Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mosaic ImmunoEngineering and related companies with MarketBeat.com's FREE daily email newsletter.
-etf-logo-1200x675.png?v=20241022134833&h=45&w=95&zc=2){kind=logo}
